Paul Jaminet on Pioneering Cancer Therapies & Leadership in Biotech

Show Notes

In this episode of Life Science Success, we sit down with Paul Jaminet, Ph.D., founder and CEO of Angiex, Inc., to explore his groundbreaking work in developing Nuclear-Delivered Antibody-Drug Conjugates™ for cancer therapy. Paul shares his unique career journey from astrophysics to biotech, insights into leading innovative projects, and the challenges and triumphs of pushing the boundaries in cancer treatment. Don't miss this inspiring conversation with a visionary leader in the life sciences.

🔗 Learn more about Angiex, Inc.: https://angiex.com/ 📚 Discover Paul's book, "Perfect Health Diet": https://www.amazon.com/Perfect-Health... 🎙️ Subscribe for more insights from top industry leaders!

In this episode of Life Science Success, host Don interviews Paul Jaminet, founder and CEO of Angenex. Paul shares his unique journey from astrophysics to life sciences, detailing his groundbreaking work in developing nuclear delivered antibody drug conjugates targeting angiogenic tumor vasculature. Learn about the challenges, motivations, and scientific discoveries driving Angenex's success.

Sponsored by D3 Digital Media Marketing.

00:00 Introduction to Life Science Success Podcast

00:41 Sponsor Message from D3 Digital Media Marketing

01:23 Interview with Paul Jaminet: Founder and CEO of Angenex

01:45 Paul Jaminet's Journey from Astrophysics to Life Sciences

04:35 The Birth of Angenex and Its Groundbreaking Work

06:34 Challenges and Innovations in Developing Antibody Drug Conjugates

13:07 Phase One Clinical Trials and Progress

25:59 Leadership and Strategic Decisions in Biotech

37:10 Inspiration and Motivation Behind the Work

41:10 Concerns and Future Outlook

46:00 Conclusion and Final Thoughts

Please check out our Life Science Success Resources. You will find tools that will support growing companies and books for authors I have interviewed.